Bio Capital Holdings, LLC
USPTO PatentsView assignee record - 16 granted patents across 19 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).
The verdict
According to USPTO PatentsView, Bio ranks #17,490 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 19 technology areas.
- #17,490
- of 49,997 US assignees by volume
- Top 11%
- by Innovation Score (51.9/100)
- 22.3
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R17490 · US Corporation #17,490 · 16 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 16 grants
- MID-PACK #17,490/49,997
- PHOTO-FINISH Bardex
- CPC-FOCUS C12N · 19 areas
- INNOV-PAR 51.9/100
- CLAIMS-DENSE 22.3 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2021–2025 · 5y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Bardex Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Bio’s 51.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Bio
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Bio Capital Holdings · this assignee
Bio Capital Holdings · this assignee
52 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Bio's Innovation Score is 51.9/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Bio?
Each dot is one of Bio’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bio’s own 22.3 claims/patent is ABOVE the 18.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Bio's grants concentrate
Bio Capital Holdings, LLC is a focused PatentsView assignee: 19 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2023 (5 grants) versus a trough of 1 in 2022. By volume, Bio sits between Bardex Corporation and Blue Baker, LLC.
Bio's three-year grant acceleration
Bio Capital Holdings, LLC shows 8 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Bio's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Bardex
Bardex Corporation
16 patents
- Becklin Holdings
Becklin Holdings, Inc.
16 patents
- Beijing Huashi Un…
Beijing Huashi United Energy Technology and Development Co., Ltd.
16 patents
- Bendpak
BendPak, Inc.
16 patents
- Bioinventors & En…
BioInventors & Entrepreneurs Network, LLC
16 patents
- Biosphere Medical
Biosphere Medical, Inc.
16 patents
- Bioventus
Bioventus LLC
16 patents
- Blue Baker
Blue Baker, LLC
16 patents
- Bio Capital Holdi… ◀
Bio Capital Holdings, LLC
16 patents
What this shows Bio holds 16 patents at rank #17,509, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Bio
By rank, the assignees closest to #17,509 in granted patent volume.
- Bardex Corporation #17,505 · 16 patents
- Becklin Holdings, Inc. #17,506 · 16 patents
- Beijing Huashi United Energy Technology and Development Co., Ltd. #17,507 · 16 patents
- BendPak, Inc. #17,508 · 16 patents
- BioInventors & Entrepreneurs Network, LLC #17,510 · 16 patents
- Biosphere Medical, Inc. #17,511 · 16 patents
- Bioventus LLC #17,512 · 16 patents
- Blue Baker, LLC #17,513 · 16 patents
Leaders in C12N (Microorganisms OR Enzymes)
Other assignees with the most granted patents in Bio's primary technology class.
- Monsanto Technology LLC 1,335 in class
- The Regents of the University of California 1,161 in class
- Novozymes A/S 656 in class
- Immatics Biotechnologies GmbH 647 in class
- Pioneer Hi-bred International, Inc. 623 in class
- President and Fellows of Harvard College 594 in class
- Massachusetts Institute of Technology 541 in class
- The Trustees of the University of Pennsylvania 537 in class
Bio's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
52 Top 11% higher than 89% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 4 | 25.0% |
| 2022 | 1 | 6.3% |
| 2023 | 5 | 31.3% |
| 2024 | 2 | 12.5% |
| 2025partial year | 4 | 25.0% |
Which technologies does Bio Capital Holdings, LLC patent most?
Top 15 of 19 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Bio Capital Holdings, LLC's patent record in context - here's where to go next.
- Bio Capital Holdings, LLC's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
- Ranked #17,490 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Bio Capital Holdings, LLC against Bardex Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 51.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.